skip to main |
skip to sidebar
CANCER DIGEST – Aug. 22, 2020 – Women with early breast cancer treated with a single dose of targeted radiotherapy during surgery were just as likely to survive cancer free for over 8 years as women treated with surgery and conventional radiotherapy, according to a new study.
The findings, published by The BMJ Aug. 19, 2020, show that targeted radiotherapy at the time of surgery to remove the tumor is associated with around an 80% chance of avoiding a full course of conventional radiotherapy, and had fewer side effects and no difference in survival or likelihood of the cancer returning.
CANCER DIGEST – Aug. 14, 2020 – A new study has found a strong link between smoking and lower used of cancer screening services by women, and a link to more advanced disease once cancer is diagnosed. The study appears in the online journal BMJ Open.
The study led by Victor Eng of the Department of Dermatology at Stanford University used data collected from the Women’s Health Initiative, a long-running study that originally started in the 1990s and has been extended several times. This analysis of data collected from questionnaires answered by 89,058 women looked at the odds of women undergoing breast, cervical, and colorectal cancer screening tests based on smoking status.
CANCER DIGEST – Aug. 7, 2020 – Delays in breast cancer surgeries for very early stage
cancer may not affect overall survival, a new study shows, which is reassuring news for women’s the earliest stage of breast cancer whose surgeries were postponed due to the COVID-19 pandemic.
When the COVID-19 pandemic hit, many elective surgeries were postponed to ensure hospitals had staff capacity to deal with virus patients. Surgeries in the gray area between essential and elective, however concerned many, including breast cancer surgeons. Ductal carcinoma in situ (DCIS) was one such surgery.
.png)
